Sridhar Rao, MD, PhD

Publications

• Stem cell damage after chemotherapy- can we do better?

  (Tang J, Zhu N, Rao S, Carlson KS.) Best Pract Res Clin Haematol. 2019 03;32(1):31-39.

• Degenerate minigene library analysis enables identification of altered branch point utilization by mutant splicing factor 3B1 (SF3B1).

  (Gupta AK, Murthy T, Paul KV, Ramirez O, Fisher JB, Rao S, Rosenberg AB, Seelig G, Minella AC, Pillai MM.) Nucleic Acids Res. 2019 Jan 25;47(2):970-980.

• Mature IgD B cells maintain tolerance by promoting regulatory T cell homeostasis.

  (Ray A, Khalil MI, Pulakanti KL, Burns RT, Gurski CJ, Basu S, Wang D, Rao S, Dittel BN.) Nat Commun. 2019 01 14;10(1):190.

• Tumor suppressor Interferon Regulatory Factor 1 selectively blocks expression of endogenous retrovirus.

  (Stoltz KP, Jondle CN, Pulakanti K, Sylvester PA, Urrutia R, Rao S, Tarakanova VL.) Virology. 2019 01 02;526:52-60.

• HNF4A Regulates the Formation of Hepatic Progenitor Cells from Human iPSC-Derived Endoderm by Facilitating Efficient Recruitment of RNA Pol II.

  (DeLaForest A, Di Furio F, Jing R, Ludwig-Kubinski A, Twaroski K, Urick A, Pulakanti K, Rao S, Duncan SA.) Genes (Basel). 2018 Dec 28;10(1).

• Genome-Wide Maps of Transcription Regulatory Elements and Transcription Enhancers in Development and Disease.

  (Agrawal P, Heimbruch KE, Rao S.) Compr Physiol. 2018 12 13;9(1):439-455.

• A CHAF1B-Dependent Molecular Switch in Hematopoiesis and Leukemia Pathogenesis.

  (Volk A, Liang K, Suraneni P, Li X, Zhao J, Bulic M, Marshall S, Pulakanti K, Malinge S, Taub J, Ge Y, Rao S, Bartom E, Shilatifard A, Crispino JD.) Cancer Cell. 2018 Nov 12;34(5):707-723.e7.

• Frontline Science: PECAM-1 (CD31) expression in naïve and memory, but not acutely activated, CD8 T cells.

  (Newman DK, Fu G, McOlash L, Schauder D, Newman PJ, Cui W, Rao S, Johnson BD, Gershan JA, Riese MJ.) J Leukoc Biol. 2018 Nov;104(5):883-893.

• Cyclin-dependent kinase 1 (CDK1) and CDK2 have opposing roles in regulating interactions of splicing factor 3B1 with chromatin.

  (Murthy T, Bluemn T, Gupta AK, Reimer M Jr, Rao S, Pillai MM, Minella AC.) J Biol Chem. 2018 06 29;293(26):10220-10234.

• Cohesin mutations: contributors to myeloid malignancies.

  (Meyer AE, Rao S, Fisher JB.) Oncotarget. 2017 Oct 06;8(46):80107-80108.

• Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis.

  (Broglie L, Pommert L, Rao S, Thakar M, Phelan R, Margolis D, Talano J.) Blood Adv. 2017 Aug 22;1(19):1533-1536.

• Dextran Enhances the Lentiviral Transduction Efficiency of Murine and Human Primary NK Cells.

  (Nanbakhsh A, Best B, Riese M, Rao S, Wang L, Medin J, Thakar MS, Malarkannan S.) J Vis Exp. 2018 01 15(131).